Abstract
Phorbol 12-myristate 13-acetate (100 nM), a potent protein kinase C and macrophage activator, has a biphasic affect on 25(OH)D3-1 alpha-hydroxylase activity in synovial fluid macrophages from arthritis patients. After 5 h, 1 alpha, 25(OH)D3 synthesis fell from 5.2 +/- 0.1 to 1.6 +/- 0.2 pmol/h per 10(6) cells, however, after 24 h and 48 h, synthesis increased to 17.4 +/- 0.3 and 22.3 +/- 1.4 pmol/h per 10(6) cells, respectively. Although an independent short-term mechanism is suggested, protein kinase C may promote macrophage activation, thus increasing long-term 25(OH)D3-1 alpha-hydroxylase expression. Intracellular calcium and cAMP are unlikely to activate the enzyme, since 0.1 microM of the calcium ionophore, A23187, and 1 mM dibutyryl-cAMP inhibited synthesis by 87% and 79%, respectively, after 24 h.
Original language | English |
---|---|
Journal | FEBS Lett |
Volume | 311( 1) |
Publication status | Published - 12 Oct 1992 |
Keywords
- metabolism: Arthritis
- metabolism: Arthritis, Gouty
- metabolism: Arthritis, Rheumatoid
- pharmacology: Bucladesine
- pharmacology: Calcimycin
- biosynthesis: Calcitriol
- Cells, Cultured
- Dose-Response Relationship, Drug
- Humans
- drug effects: Macrophages
- Research Support, Non-U.S. Gov't
- cytology: Synovial Fluid
- pharmacology: Tetradecanoylphorbol Acetate